OPTN: OptiNose Inc Company Profile & Statistics

About

OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and AVP-825 which are in clinical stage. OptiNose Inc. is headquartered in Pennsylvania, USA.

Info & Links

CEO

Ramy Mahmoud

Headquarters

1020 STONY HILL ROAD, SUITE 300
YARDLEY, PA 19067, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

132

OptiNose Inc Statistics

Valuation Measures

Market Capitalization²

63.79M

Enterprise Value

107.27M

Enterprise Value/EBITDA(ttm)

-6.35

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.94

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

90.31%

Operating Margin(ttm)

-41.16%

Profit Margin(ttm)

-44.88%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-43.57%

Return on Assets(ttm)

-27.42%

Income Statement

Revenue(ttm)

75.67M

Revenue Per Share(ttm)

0.50

Gross Profit(ttm)

68.26M

EBITDA(ttm)³

-16.90M

Net Income Available to Common(ttm)

-31.17M

Diluted EPS(ttm)

-0.28

Share Statistics

Beta (5Y Monthly)

-0.17

52-Week Change

-71.03%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

150.83M

Dividend Yield

0.00%

Float⁴

147.36M

% Held by Insiders

2.30%

% Held by Institutions

85.60%

Balance Sheet

Total Cash(mrq)

82.50M

Total Cash Per Share(mrq)

0.55

Total Debt(mrq)

125.98M

Total Debt/Equity(mrq)

-306.56%

Current Ratio(mrq)

0.79%

Quick Ratio(mrq)

0.72%

Book Value Per Share(mrq)

-0.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.27

Free Cash Flow(ytd)

-46.62M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

OPTN

OptiNose Inc

OptiNose Inc Profile